Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56.3M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
22.8M
-
Shares change
-
+4.79M
-
Total reported value, excl. options
-
$55.8M
-
Value change
-
+$11.8M
-
Number of buys
-
24
-
Number of sells
-
-32
-
Price
-
$2.48
Significant Holders of Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) as of Q3 2025
67 filings reported holding OBIO - Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.
Orchestra BioMed Holdings, Inc. - Common Stock, par value $0.0001 per share (OBIO) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.8M shares
of 56.3M outstanding shares and own 40.44% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (8.31M shares), PERCEPTIVE ADVISORS LLC (5.29M shares), VANGUARD GROUP INC (1.48M shares), Alyeska Investment Group, L.P. (1.37M shares), Pathstone Holdings, LLC (1.01M shares), Affinity Asset Advisors, LLC (727K shares), BlackRock, Inc. (664K shares), Knoll Capital Management, LLC (455K shares), PRICE T ROWE ASSOCIATES INC /MD/ (422K shares), and GEODE CAPITAL MANAGEMENT, LLC (387K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.